Taking Action for Lockdown Harms » Blog » Smoking Gun: SARS-CoV-2 Patents Exposed!

Smoking Gun: SARS-CoV-2 Patents Exposed!

Dr. David Martin, legal and technical expert, summarises reams of evidence to the Corona Committee in this video.

Dr. Martin’s company is “the world’s largest underwriter of intangible assets used in finance in 168 countries.  Our underwriting systems [include] patents, patent applications, federal grants, procurement records, e-government records, etc.  We have the ability to not only track what is happening, who is involved in what’s happening…  Our business is to monitor the innovation that’s happening around the world.  And […] the degree to which financial interests are being served, corporate interests are being dislocated etc., etc.”

So, David Martin knows what he’s talking about when it comes to patents, and is able to speak authoritatively when it comes to issues such as racketeering and insider trading.  This is exactly what he says the evidence points towards: a RICO case.

“The declaration of a novel coronavirus was a fallacy.”

He begins by explaining that his company has reviewed over 4,000 patents filed and issued between 2008 and 2020.  Over 120 of these pieces of evidence “suggest that the declaration of a novel coronavirus was entirely a fallacy… There was no novel coronavirus…

“We found records, in the patent records, of sequences attributed to novelty, going to patents that were sought as early as 1999… So… it’s not been novel for over two decades.”

David Martin explains how the first vaccine patented for coronavirus was sought by Pfizer 21 years ago on 28 January, 2000.  It was specifically for the same S-spike protein that has allegedly been rushed into invention now…

Dr. Reiner Fuellmich and his team are clearly astonished at each segment of the interview, as Martin keeps telling them, “It gets worse.”

“We.  Made.  SARS.”

US government adviser for over five decades, Dr. Anthony Fauci, is directly implicated in the work that the US did in creating, and then patenting, an “infectious, replication-defective coronavirus” targeted for human lung epithelium.  Fauci funded the work in 1999 and the patent was filed on 19 April 2002, several months before the first SARS outbreak in China.

The CDC lied to the patent office

The CDC is also uncovered as patenting the gene sequence of covonavirus and also the means of detecting it.  But the CDC’s application for its coronavirus patent was rejected twice by the patent office as “unpatentable” because it was already in the public domain.  Given that the CDC’s reason for applying for the patent was so that everyone would be free to research it, why would they pay for an appeal to override the patent office’s decision, and ensure they received the patent (unless, as Martin states, they lied)?

Highlights, Key Takeaways and Lookups:

  • Dr Fauci and his organisation NIAID found the malleability of coronavirus made it a potential candidate for HIV vaccines.
  • 73 patents on everything stated to be clinically “novel” (in SARS-CoV-2) were all issued before 2019.
  • 1999: Fauci funded research to create an “infectious, replication-defective coronavirus” targeted for human lung epithelium.
  • 2000: Pfizer filed for patent No. 6372224, for a coronavirus vaccine targeting the S-spike protein.
  • 2002: patent No. 7279327, filed on 19 April 2002, was the result of the work funded by Fauci for the lung tissue-targeting coronavirus.  Followed several months later by what was termed “SARS.”
  • 2015: patent No. 9193780, filed 29 November 2015, after the United States’ Gain of Function moratorium and after the MERS “outbreak” in the Middle East.
  • 2016, 2017 & 2019: patents covering RNA strands and sub-componenets of the gene strands were issued to Ablynx (Sanofi), Crusell (J&J), Rubius Therapeutics, Children’s Medical Corporation and others.
  • Patent Nos. 7220852, 46592703P & 7776521: you cannot patent a naturally occuring thing.  But the CDC has managed it.

See more...

Leave a Reply

Your email address will not be published. Required fields are marked *